60 Degrees Pharmaceuticals, Inc. (SXTP)

1.04 +0.01 (+0.97%) USD  |  NASDAQ  |  Aug 31, 16:00
1.04 0.00 (0.00%) After-Hours: 20:00
More

60 Degrees Pharmaceuticals Cash from Operations (Annual) : -6.849M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for SXTP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2020. Start Trial.
Date Value
December 31, 2025 -6.849M
December 31, 2024 -5.648M
December 31, 2023 -4.543M
Date Value
December 31, 2022 -1.01M
December 31, 2021 -0.6491M
December 31, 2020 -0.1673M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Harrow, Inc. 43.86M
ANI Pharmaceuticals, Inc. 185.22M
Corcept Therapeutics, Inc. 142.00M
Veru, Inc. -30.04M
Johnson & Johnson 24.53B